Clinical Trials Using Liposomal Bcl-2 Antisense Oligonucleotide BP1002
Review the clinical trials studying liposomal bcl-2 antisense oligonucleotide bp1002 on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.
You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.
Trials 1-1 of
1
- Status: ActiveLocation: UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California